Koers RLS Global AB (publ) Nasdaq Stockholm
Aandelen
SE0005190725
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 01-01-21 |
Director of Finance/CFO | 64 | 22-08-23 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 71 | 01-08-12 | |
Director/Board Member | 63 | 01-08-17 | |
Anders Edvell
BRD | Director/Board Member | 55 | 01-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |